BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 29512278)

  • 1. Genetic analysis of PALB2 gene WD40 domain in canine mammary tumour patients.
    Çıldır ÖŞ; Özmen Ö; Kul S; Rişvanlı A; Özalp G; Sabuncu A; Kul O
    Vet Med Sci; 2024 May; 10(3):e1366. PubMed ID: 38527110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of DNA mutation in the coding region and DNA methylation in the 5' flanking region of BRCA1 in canine mammary tumors.
    Qiu H; Lin D
    J Vet Med Sci; 2016 Jul; 78(6):943-9. PubMed ID: 26888582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Serum and Salivary Proteins in Canine Mammary Tumors.
    Franco-Martínez L; Gelemanović A; Horvatić A; Contreras-Aguilar MD; Dąbrowski R; Mrljak V; Cerón JJ; Martínez-Subiela S; Tvarijonaviciute A
    Animals (Basel); 2020 Apr; 10(4):. PubMed ID: 32344524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
    Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
    Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours.
    Canadas-Sousa A; Santos M; Medeiros R; Dias-Pereira P
    J Comp Pathol; 2019 Oct; 172():72-79. PubMed ID: 31690419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes.
    Canadas A; Santos M; Nogueira A; Assis J; Gomes M; Lemos C; Medeiros R; Dias-Pereira P
    J Vet Diagn Invest; 2018 Sep; 30(5):733-738. PubMed ID: 30027822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future.
    Aupperle-Lellbach H; Kehl A; de Brot S; van der Weyden L
    Vet Sci; 2024 May; 11(5):. PubMed ID: 38787171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Highly Conserved Region in BRCA2 Suppresses the RAD51-Interaction Activity of BRC Repeats.
    Zhu Z; Kitano T; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Oosumi K; Lin X; Orino K; Yoshikawa Y
    Vet Sci; 2023 Feb; 10(2):. PubMed ID: 36851449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Novel Diagnostic Techniques and Biomarkers of Canine Mammary Tumors.
    Kaszak I; Witkowska-Piłaszewicz O; Domrazek K; Jurka P
    Vet Sci; 2022 Sep; 9(10):. PubMed ID: 36288138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of AmpliSeq NGS Panel for
    Di Giacomo D; Di Domenico M; Defourny SVP; Malatesta D; Di Teodoro G; Martino M; Viola A; D'Alterio N; Cammà C; Modesto P; Petrini A
    Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer.
    Colombo J; Moschetta-Pinheiro MG; Novais AA; Stoppe BR; Bonini ED; Gonçalves FM; Fukumasu H; Coutinho LL; Chuffa LGA; Zuccari DAPC
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2.
    Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Morioka R; Okuda K; Orino K
    J Vet Med Sci; 2021 May; 83(5):759-766. PubMed ID: 33731496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common germline haplotypes and genotypes identified in BRCA2 exon 11 of dogs with mammary tumours and histopathological analyses.
    Maués T; El-Jaick KB; Costa FB; Araujo GEF; Soares MVG; Moreira AS; Ferreira MLG; Ferreira AMR
    Vet Comp Oncol; 2018 Sep; 16(3):379-384. PubMed ID: 29512278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic SNPs of the BRCA2 gene at the fragments encoding RAD51 binding sites of canine mammary tumors.
    Ozmen O; Kul S; Risvanli A; Ozalp G; Sabuncu A; Kul O
    Vet Comp Oncol; 2017 Dec; 15(4):1479-1486. PubMed ID: 28133886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3.
    Yoshikawa Y; Ochiai K; Morimatsu M; Suzuki Y; Wada S; Taoda T; Iwai S; Chikazawa S; Orino K; Watanabe K
    PLoS One; 2012; 7(10):e45833. PubMed ID: 23071527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue.
    Hsu WL; Huang YH; Chang TJ; Wong ML; Chang SC
    Vet J; 2010 Jun; 184(3):351-6. PubMed ID: 19944633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.
    Thumser-Henner P; Nytko KJ; Rohrer Bley C
    BMC Vet Res; 2020 Jan; 16(1):30. PubMed ID: 32005245
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.